View Author
screening cancer prostate result prostate cancer biopsy round study erspc center cohort european model diagnosis disease european randomized study fp results follow-up fp result table value finland centre randomized screening arm trial prostate-speci fic antigen level finnish prostate volume netherland roobol antigen interval detection speci risk calculator calculator number prostate biopsy sweden erspc risk calculator effect outcome urology analysis volume screen dutch metastatic disease schroder psa level fi ve centres control psa velocity metastatic ficant signi velocity predictor swedish cohort reduction risk reduction swedish dutch cohort nomogram biopsied cancer 4 7 population european randomised study threshold italy death biopsy outcome prostate-speci control arm validation serum proportion prostate cancer screening
4 Most Recent Publications
|
Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
(Article)
Schröder, F.H. Hugosson, J. Carlsson, S. Tammela, T.L. Määttänen, L. Auvinen, A. Kwiatkowski, M. Recker, F. Roobol, M.J. |
2012-11-01
|
|
False-positive screening results in the European randomized study of screening for prostate cancer
(Article)
Kilpeläinen, T.P. Tammela, T.L. Roobol, M.J. Hugosson, J. Ciatto, S. Nelen, V. Moss, S. Määttänen, L. Auvinen, A. |
2011-12-01
|
|
Prediction of prostate cancer in unscreened men: External validation of a risk calculator
(Article)
Vugt, H.A. van Roobol, M.J. Kranse, R. Määttänen, L. Finne, P. Hugosson, J. Bangma, C.H. Schröder, F.H. Steyerberg, E.W. |
2011-04-01
|
|
The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC)
(Article)
Roobol, M.J. Zappa, M. Määttänen, L. Ciatto, S. |
2007-03-01
|
